Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2003-12-11
pubmed:abstractText
Liquid chromatography in combination with mass spectrometry (LC-MS) is key to the identification of metabolites in new molecular imaging probes. These metabolites can be generated using hepatocytes from various species in vitro. Metabolites produced from 4-fluoro-N-[2-[4-(2-methoxylphenyl)piperazino]ethyl]-N-(2-pyridyl)cyclohexane carboxamide (FCWAY) using rat and human hepatocytes are different, whereas metabolites from (3-(3-fluoropropylthio)-1,2,5-thiadiazol-4-yl)-tetrahydro-l-methyl-pyridine (FP-TZTP) using rat and human hepatocytes were similar. The combination of LC-MS and hepatocytes are an indispensable tool in the development of new molecular imaging probes.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1536-1632
pubmed:author
pubmed:issnType
Print
pubmed:volume
5
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
397-403
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:articleTitle
Application of LC-MS to the analysis of new radiopharmaceuticals.
pubmed:affiliation
PET Department, Warren G. Magnuson Clinical Center, NIH, Bethesda, MD 20892, USA.
pubmed:publicationType
Journal Article, In Vitro